196 related articles for article (PubMed ID: 36615181)
21. Low Responsiveness of Basophils via FcεRI Reflects Disease Activity in Chronic Spontaneous Urticaria.
Oda Y; Fukunaga A; Washio K; Imamura S; Hatakeyama M; Ogura K; Nishigori C
J Allergy Clin Immunol Pract; 2019; 7(8):2835-2844.e7. PubMed ID: 31136822
[TBL] [Abstract][Full Text] [Related]
22. Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy.
Deza G; Bertolín-Colilla M; Pujol RM; Curto-Barredo L; Soto D; García M; Hernández P; Gimeno R; Giménez-Arnau AM
Acta Derm Venereol; 2017 Jun; 97(6):698-704. PubMed ID: 28303277
[TBL] [Abstract][Full Text] [Related]
23. Lin
Ridge K; Moran B; Alvarado-Vazquez PA; Hallgren J; Little MA; Irvine AD; O'Farrelly C; Dunne J; Finlay CM; Conlon N
Allergy; 2024 Apr; ():. PubMed ID: 38634175
[TBL] [Abstract][Full Text] [Related]
24. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?
Altrichter S; Peter HJ; Pisarevskaja D; Metz M; Martus P; Maurer M
PLoS One; 2011 Apr; 6(4):e14794. PubMed ID: 21532759
[TBL] [Abstract][Full Text] [Related]
25. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.
MacGlashan D; Saini S; Schroeder JT
J Allergy Clin Immunol; 2021 Jun; 147(6):2295-2304.e12. PubMed ID: 33716077
[TBL] [Abstract][Full Text] [Related]
26. Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria.
Rauber MM; Pickert J; Holiangu L; Möbs C; Pfützner W
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2078-2085. PubMed ID: 31954076
[TBL] [Abstract][Full Text] [Related]
27. Detection of circulating IgG autoantibody to FcεRIα in sera from chronic spontaneous urticaria patients.
Ulambayar B; Chen YH; Ban GY; Lee JH; Jung CG; Yang EM; Park HS; Ye YM
J Microbiol Immunol Infect; 2020 Feb; 53(1):141-147. PubMed ID: 29169972
[TBL] [Abstract][Full Text] [Related]
28. Quantity increase and functional affinity/avidity decrease of anti-FcεRI and anti-IgE autoantibodies in chronic spontaneous urticaria.
Jörg L; Müller-Wirth N; Kammermann K; Stalder O; Pichle W; Hausmann O
Eur Ann Allergy Clin Immunol; 2023 Dec; ():. PubMed ID: 38088172
[No Abstract] [Full Text] [Related]
29. Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment.
Kolkhir P; Church MK; Altrichter S; Skov PS; Hawro T; Frischbutter S; Metz M; Maurer M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):318-325.e5. PubMed ID: 31472293
[TBL] [Abstract][Full Text] [Related]
30. Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience from a Tertiary Care Institution.
Deza G; March-Rodríguez A; Sánchez S; Ribas-Llauradó C; Soto D; Pujol RM; Gimeno R; Giménez-Arnau AM
J Allergy Clin Immunol Pract; 2019; 7(5):1619-1626.e1. PubMed ID: 30685572
[TBL] [Abstract][Full Text] [Related]
31. Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria.
Jang JH; Moon J; Yang EM; Ryu MS; Lee Y; Ye YM; Park HS
PLoS One; 2022; 17(8):e0273415. PubMed ID: 35984815
[TBL] [Abstract][Full Text] [Related]
32. Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria.
Endo T; Toyoshima S; Hayama K; Tagui M; Niwa Y; Ito M; Terui T; Okayama Y
Asia Pac Allergy; 2020 Apr; 10(2):e12. PubMed ID: 32411577
[TBL] [Abstract][Full Text] [Related]
33. Autoreactive IgE in Chronic Spontaneous/Idiopathic Urticaria and Basophil/Mastocyte Priming Phenomenon, as a Feature of Autoimmune Nature of the Syndrome.
Panaszek B; Pawłowicz R; Grzegrzółka J; Obojski A
Arch Immunol Ther Exp (Warsz); 2017 Apr; 65(2):137-143. PubMed ID: 27582030
[TBL] [Abstract][Full Text] [Related]
34. Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU).
Jang JH; Yang EM; Lee Y; Ye YM; Moon J; Ryu MS; Park HS
World Allergy Organ J; 2022 Feb; 15(2):100629. PubMed ID: 35280503
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers of Autologous Whole Blood Injection Efficacy in Patients with Chronic Spontaneous Urticaria with Autoreactivity: A Preliminary Study.
Chen Q; Luo J; Yang X; Chen W; Liu W; Song Z
Int Arch Allergy Immunol; 2024; 185(2):190-195. PubMed ID: 37952519
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune chronic spontaneous urticaria: What we know and what we do not know.
Kolkhir P; Church MK; Weller K; Metz M; Schmetzer O; Maurer M
J Allergy Clin Immunol; 2017 Jun; 139(6):1772-1781.e1. PubMed ID: 27777182
[TBL] [Abstract][Full Text] [Related]
37. Omalizumab may not inhibit mast cell and basophil activation in vitro.
Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
[TBL] [Abstract][Full Text] [Related]
38. Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU.
Sella JA; Ferriani MPL; Melo JML; Trevisan Neto O; Zanetti MET; Cordeiro DL; Lemos JE; Barros SA; Aragon DC; Arruda LK
J Allergy Clin Immunol Glob; 2023 Nov; 2(4):100159. PubMed ID: 37781653
[TBL] [Abstract][Full Text] [Related]
39. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
Maurer M; Khan DA; Elieh Ali Komi D; Kaplan AP
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1067-1078. PubMed ID: 33685605
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study.
Oztop N; Demir S; Unal D; Beyaz S; Terzioglu K; Olgac M; Gelincik A
Allergy Asthma Proc; 2022 Nov; 43(6):519-528. PubMed ID: 36335414
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
